Anticonvulsant therapy

Irish Veterinary Journal

Volumn 56, Issue 2, 2003, Pages 99-106

  Platt, Simon ^a  

^a ANIMAL HEALTH TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTICONVULSIVE AGENT; CLONAZEPAM; CLORAZEPATE DIPOTASSIUM; DIAZEPAM; EPILEASE; EPIPHEN; ETIRACETAM; GABAPENTIN; LIVER ENZYME; PHENOBARBITAL; PHENYTOIN; POTASSIUM BROMIDE; PRIMIDONE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL BEHAVIOR; ANTICONVULSANT THERAPY; BONE MARROW SUPPRESSION; BULIMIA; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; DRUG TOLERANCE; EPILEPSY; JAUNDICE; LIVER INJURY; LIVER NECROSIS; LIVER TOXICITY; MUSCLE STIFFNESS; MUSCLE WEAKNESS; NEUTROPENIA; NONHUMAN; POLYDIPSIA; POLYURIA; RESTLESSNESS; REVIEW; SEIZURE; SKIN ALLERGY; SLOW RELEASE FORMULATION; SPECIES DIFFERENCE; THROMBOCYTOPENIA; TREATMENT INDICATION; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ANIMALIA; CANIS FAMILIARIS; FELIS CATUS;

EID: 0037312678     PISSN: 03680762     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Boothe, D.M. (1998). Anticonvulsant therapy in small animals. Veterinary Clinics of North America: Small Animal Practice 28: 411-448.
2. Center, S.A., Elston, T.H., Rowland, P.H., Rosen, D.K., Reitz, B.L., Brunt, J.E., Rodan, I., House, J., Bank, S., Lynch, L.R., Dring, L.A. and Levy, J.K. (1996). Fulminant hepatic failure associated with oral administration of diazepam in 11 cats. Journal of the American Veterinary Medical Association 209: 618-625.
3. Dayrell-Hart, B., Steinberg, S.A., VanWinkle, T.J. and Farnbach, G.C. (1991). Hepatotoxicity of phenobarbital in dogs: 18 cases (1985-1989). Journal of the American Veterinary Medical Association 199: 1060-1066.
4. Dunnett, M., Littleford, A. and Lees, P. (2002). Phenobarbitone concentrations in the hair, saliva and plasma of eight epileptic dogs. Veterinary Record 150: 718-724.
5. Farnbach, G.C. (1984). Serum concentrations and efficacy of phenytoin, phenobarbital, and primidone in canine epilepsy. Journal of the American Veterinary Medical Association 184: 1117-1120.
6. Gaskill, C.L., Burton, S.A., Gelens, H.J.C., Ihle, S.L., Miller, J.B., Shaw, D.H., Brihacombe, M.B. and Cribb, A.E. (1999). Effects of phenobarbital treatment on serum thyroxine and thyroid-stimulating hormone concentrations in epileptic dogs. Journal of the American Veterinary Medical Association 215: 489-496.
7. Gieger, T.L., Hosgood, G., Taboada, J., Wolfeimer, K.J. and Mueller, P.B. (2000). Thyroid function and serum hepatic enzyme activity in dogs after phenobarbital administration. Journal of Veterinary Internal Medicine 14: 277-281.
8. Hachad, H., Ragueneau-Majlessi, I. and Levy, R.H. (2002). New antiepileptic drugs: Review on drug interactions. Therapeutic Drug Monitoring 24: 91-103.
9. Heynold, Y., Faissler, D., Steffen, F., and Jaggy, A. (1997). Clinical, epidemiological and treatment results of idiopathic epilepsy in 54 labrador retrievers: A long-term study. Journal of Small Animal Practice 38: 7-14.
10. Kantrowitz, L.B., Peterson, M.E., Trepanier, L.A., Melian, C. and Nichols, R. (1999). Serum total thyroxine, total triiodothyronine, free thyroxine, and thyrotropin concentrations in epileptic dogs treated with anticonvulsants. Journal of the American Veterinary Medical Association 214: 1804-1808.
11. Lane, S.B. and Bunch, S.E. (1990). Medical management of recurrent seizures in dogs and cats. Journal of Veterinary Internal Medicine 4: 26-39.
12. Levitski, R.E. and Trepanier, L.A. (2000). Effect of timing of blood collection on serum phenobarbital concentrations in dogs with epilepsy. Journal of the American Veterinary Medical Association 217: 200-204.
13. March, P.A. (1998). Seizures: Classification, etiologies, and pathophysiology. Clinical Techniques in Small Animal Practice 13: 119-131.
14. Nichols, E.S., Trepanier, L.A. and Linn, K. (1996). Bromide toxicosis secondary to renal insufficiency in an epileptic dog. Journal of the American Veterinary Medical Association 208: 231-233.
15. Pearce, L.K. (1990). Potassium bromide as an adjunct to phenobarbital for the management of uncontrolled seizures in dogs. Progress in Veterinary Neurology 1: 95-101.
16. Platt, S.R. (2001). Feline seizure control. Journal of the American Animal Hospital Association 37: 515-517.
17. Podell, M. and Fenner, W.R. (1993). Bromide therapy in refractory canine idiopathic epilepsy. Journal of Veterinary Internal Medicine 7: 318-327.
18. Podell, M. (1995). The use of diazepam per rectum at home for the acute management of cluster seizures in dogs. Journal of Veterinary Internal Medicine 8: 68-74.
19. Radtke, R.A. (2001). Pharmacokinetics of levetiracetam. Epilepsia 42 (Suppl.4): 24-27.
20. Schachter, S.C. (2000). The new wave of anticonvulsant: focus on levetiracetam, oxcarbazepine and zonisamide. CNS Drugs 14: 229-249.
21. Schwartz-Porsche, D., Loscher, W. and Frey, H-H. (1985). Therapeutic efficacy of phenobarbitone and primidone in canine epilepsy: A comparison. Journal of Veterinary Pharmacological Therapy 8: 113-119.
22. Trepanier, L.A., van Schoick, A., Schwark, W. S. and Carillo, J. (1998). Therapeutic serum drug concentrations in epileptic dogs treated with potassium bromide alone or in combination with other anticonvulsants: 122 cases (1992-1996). Journal of the American Veterinary Medical Association 213: 1449-1453.
23. Trepanier, L.A. (2002). Mechanisms of drug-associated hepatotoxicity in the dog and cat. Proceedings of the 20th ACVIM Forum. Dallas, Texas. pp 669-671.
24. Wagner, S.O. (2001). Lower airway disease in cats on bromide therapy for seizures. Proceedings of the 19th ACVIM Forum. Denver, CO. pp 562.